1-(SUBSTITUTED-BENZYL)IMIDAZOLE-2(3H)-THIONE INHIBITORS OF DOPAMINE BETA-HYDROXYLASE

被引:15
作者
BURKE, BJ [1 ]
HOPFINGER, AJ [1 ]
机构
[1] UNIV ILLINOIS,DEPT MED CHEM & PHARMACOGNOSY,BOX 6998 M-C 781,CHICAGO,IL 60680
关键词
D O I
10.1021/jm00163a045
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Molecular shape and quantitative structure-activity relationship (QSAR) analyses of 52 l-(substituted-benzyl)-imidazole-2(3H)-thione inhibitors of dopamine β-hydroxylase were carried out. QSARs were developed for sets of 45 and sets of 47 analogues. Molecular shape, as represented by common overlap steric volume and the composite charge density on carbons 3, 4, and 5 of the substituted-benzyi ring are the major inhibition-potency descriptors. Five of the 52 compounds were eliminated prior to analyses on the basis of difficulties in characterizing shape and charge state. Two compounds were outliers. The active conformation deduced in the analyses is a low-energy conformer for both active and inactive inhibitors. This suggests that the intrinsic shape of the molecule due to the selection of X is more important than torsion-angle selection for the bonds between the two rings. The QSARs found in this study have only general similarities to one put forth by Kruse et al. using linear free energy descriptors. © 1990, American Chemical Society. All rights reserved.
引用
收藏
页码:274 / 281
页数:8
相关论文
共 14 条
[1]   CONFORMATIONAL-ANALYSIS .130. MM2 - HYDROCARBON FORCE-FIELD UTILIZING V1 AND V2 TORSIONAL TERMS [J].
ALLINGER, NL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1977, 99 (25) :8127-8134
[2]  
[Anonymous], 1970, APPROXIMATE MOL ORBI
[3]  
[Anonymous], CONFORMATIONAL PROPE
[4]  
CRAWFORD RJ, 1989, TETRAHEDRON COMPUT M, V1, P185
[5]  
Hansch C., 1979, SUBSTITUENT CONSTANT
[6]  
HOPFINGER AJ, 1980, J AM CHEM SOC, V120, P7196
[7]  
HOPFINGER AJ, 1989, QSAR QUANTITATIVE ST, P151
[8]   MULTISUBSTRATE INHIBITORS OF DOPAMINE BETA-HYDROXYLASE .2. STRUCTURE-ACTIVITY-RELATIONSHIPS AT THE PHENETHYLAMINE BINDING-SITE [J].
KRUSE, LI ;
KAISER, C ;
DEWOLF, WE ;
FRAZEE, JS ;
ROSS, ST ;
WAWRO, J ;
WISE, M ;
FLAIM, KE ;
SAWYER, JL ;
ERICKSON, RW ;
EZEKIEL, M ;
OHLSTEIN, EH ;
BERKOWITZ, BA .
JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (03) :486-494
[9]  
MABILIA M, 1985, EUR J MED CHEM, V28, P1133
[10]  
MABILIA M, 1986, MOL GRAPHICS DRUG DE, P158